Account
Inquiry
QSC Tirzepatide is a novel GLP-1 receptor agonist with demonstrated efficacy in weight management and glycemic control applications. This pharmaceutical-grade peptide is supplied as lyophilized powder with purity exceeding 99.9%, making it ideal for research purposes.
As a triple agonist targeting GIP, GLP-1 and glucagon receptors, QSC Tirzepatide represents an advanced therapeutic approach for metabolic disorders. The product is manufactured under strict quality controls in our GMP-compliant facility.
Storage recommendations include maintaining the product in a cool, dry environment protected from light. For optimal stability, avoid repeated freeze-thaw cycles and prolonged exposure to solution phase.
Our production advantages include: batch-to-batch consistency, comprehensive analytical documentation, and flexible packaging options to meet diverse research requirements.
This product is intended for research use only and not for human consumption. Proper handling procedures should be followed by qualified researchers in controlled laboratory settings.
